ZB6-17491-64602
3 vaccinations
1 coded response
33 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 900 / CA
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Moderna
-
2021-01-10
Registered in v-safe
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-07
-
2021-02-08
Dose 2 — Moderna
- 2021-02-08
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-11
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-24
-
2021-08-11
Survey response — 6 months, dose 2MedDRA: COVID-19 pneumonia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: covid neumoniaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-11
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-13
- 2021-08-18
-
2021-11-10
Dose 3 — Moderna
-
2021-11-11
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-11-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-16
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-17
- 2021-12-22
- 2022-11-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-08 | Moderna | |
| 3 | 2021-11-10 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-10 | priority 2/3 | |
| 2021-08-11 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: covid neumonia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 pneumonia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release